Cambridge Investment Research Advisors’s Capital Group Dividend Growers ETF CGDG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62M Buy
1,652,776
+65,554
+4% +$2.44M 0.14% 131
2026
Q1
$57M Buy
1,587,222
+256,719
+19% +$9.4M 0.15% 126
2025
Q4
$47.4M Buy
1,330,503
+421,420
+46% +$14.8M 0.13% 153
2025
Q3
$31.5M Buy
909,083
+88,606
+11% +$3.02M 0.09% 234
2025
Q2
$27.6M Buy
820,477
+216,001
+36% +$6.86M 0.08% 244
2025
Q1
$18.7M Buy
604,476
+120,192
+25% +$3.7M 0.06% 304
2024
Q4
$14.4M Buy
484,284
+80,683
+20% +$2.45M 0.05% 375
2024
Q3
$12.4M Buy
403,601
+258,007
+177% +$7.63M 0.04% 425
2024
Q2
$4.14M Buy
145,594
+74,560
+105% +$2.12M 0.02% 855
2024
Q1
$2.03M Buy
71,034
+34,054
+92% +$939K 0.01% 1251
2023
Q4
$1M Buy
+36,980
New +$946K ﹤0.01% 1656

Other funds holding CGDG

Cambridge Investment Research Advisors's CGDG Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Capital Group Dividend Growers ETF (CGDG) stake by 4.1% in Q2 2026, buying an estimated $2.44M and bringing the position to 1,652,776 shares worth $62M. The position accounts for 0.14% of the portfolio, ranked #131.

Cambridge Investment Research Advisors first reported a position in CGDG in Q4 2023 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold CGDG as of Q2 2026.

  • Cambridge Investment Research Advisors held 1,652,776 shares of Capital Group Dividend Growers ETF worth $62M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 65,554 Capital Group Dividend Growers ETF shares in Q2 2026, an estimated $2.44M.
  • Capital Group Dividend Growers ETF made up 0.14% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #131 holding.
  • Cambridge Investment Research Advisors first reported a position in Capital Group Dividend Growers ETF in Q4 2023 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held Capital Group Dividend Growers ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.